Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)

STO:NEWBRY Balance Sheet

Financials in millions SEK. Fiscal year is September - August.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	7.92	14.56	15.3	8.53	33.33	13.15
Cash & Short-Term Investments	7.92	14.56	15.3	8.53	33.33	13.15
Cash Growth	-59.25%	-4.84%	79.44%	-74.42%	153.59%	-
Accounts Receivable	-	7.06	15.24	9.12	0	1.08
Other Receivables	28.57	14.17	7.01	6.39	0.79	1.25
Receivables	28.57	21.23	22.25	15.51	0.79	2.33
Inventory	9.7	9	5	2.11	1.77	-
Prepaid Expenses	-	1.67	1.42	1.09	0.58	0.29
Total Current Assets	46.19	46.46	43.97	27.24	36.47	15.77
Goodwill	-	0.34	1.26	2.13	3.04	3.95
Other Intangible Assets	30.39	30.55	45.64	43.55	47.39	23.09
Total Assets	76.58	77.35	90.87	72.92	86.91	42.81
Accounts Payable	-	7.32	1.94	4.28	2.04	1.88
Accrued Expenses	-	4.46	6.28	3.19	0.89	2.23
Current Income Taxes Payable	-	0.35	0.08	0.16	0.18	0.07
Current Unearned Revenue	-	-	-	1.63	-	-
Other Current Liabilities	37.02	18.72	21.14	2.52	2.96	0.16
Total Current Liabilities	37.02	30.85	29.45	11.77	6.06	4.34
Other Long-Term Liabilities	3.72	3.75	9.51	11.77	12.08	-
Total Liabilities	40.73	34.6	38.95	23.54	18.14	4.34
Common Stock	35.85	0.97	0.77	0.62	0.62	0.16
Additional Paid-In Capital	-	121.9	106.72	88.71	88.71	43.89
Comprehensive Income & Other	-	-80.12	-55.58	-39.96	-20.57	-5.58
Shareholders' Equity	35.85	42.75	51.92	49.38	68.77	38.47
Total Liabilities & Equity	76.58	77.35	90.87	72.92	86.91	42.81
Net Cash (Debt)	7.92	14.56	15.3	8.53	33.33	13.15
Net Cash Growth	-59.25%	-4.84%	79.44%	-74.42%	153.59%	-
Net Cash Per Share	-	0.56	0.71	0.44	1.87	-
Filing Date Shares Outstanding	-	30.4	24.26	19.52	19.52	15.68
Total Common Shares Outstanding	-	30.4	24.26	19.52	19.52	15.68
Working Capital	9.18	15.61	14.53	15.47	30.42	11.43
Book Value Per Share	-	1.41	2.14	2.53	3.52	2.45
Tangible Book Value	5.46	11.87	5.02	3.7	18.34	11.43
Tangible Book Value Per Share	-	0.39	0.21	0.19	0.94	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.